Study Presented at American Diabetes Association 79th Scientific Sessions Observed Substantially Less Hypoglycemia With Use of Glytec’s Technology

Results of a study by Drs. Guillermo Umpierrez and Jordan Messler
observed markedly lower rates of hypoglycemia and hyperglycemia among
critical care patients managed with Glytec’s eGlycemic Management System
®
versus usual care.

WALTHAM, Mass.–(BUSINESS WIRE)–#A1C–Delivering the highest quality care in accordance with best practice is
a fundamental tenet of diabetes and glycemic management at Grady
Hospital
of Atlanta, Georgia, which is why in 2016, the academic
medical center chose to standardize its approach and elevate both safety
and efficacy by implementing Glytec’s eGlycemic
Management System®
(eGMS®) in its intensive
care and step-down units. A retrospective analysis conducted by Drs.
Guillermo Umpierrez and Jordan Messler, and presented at the American
Diabetes Association 79th Scientific Sessions, observed that outcomes of
patients managed with eGMS® were consistently superior to
those managed with a standard protocol. Outcomes measured over a
two-year period (December 2016 to December 2018) included incidence of
hypoglycemia, incidence of hyperglycemia, target glucose attainment, and
reduction in admission-to-discharge blood glucose.

Representative Outcomes From Study

Outcomes    

Glytec eGMS®

    Usual Care     Difference in Rate     p Value
% BGs <40 mg/dL     0.02%     0.44%    

95.5% less with eGMS®

    <0.01
% BGs <54 mg/dL     0.08%     1.02%    

92.2% less with eGMS®

    <0.01
% BGs <70 mg/dL     0.32%     2.44%    

86.9% less with eGMS®

    <0.01
% BGs >250 mg/dL     7.00%     10.10%    

30.7% less with eGMS®

    <0.01
% BGs 70-180 mg/dL     69.80%     66.34%    

5.2% more with eGMS®

    <0.01
               

With a continual influx of new resident physicians from both Emory
University School of Medicine
and Morehouse
School of Medicine
, systemization with Glytec’s technology has
proven a valuable teaching mechanism, especially given Grady Hospital is
the primary destination for many of Georgia’s most complex cases.

This study demonstrated that personalization of insulin therapy with an
evidence-based system’s approach is superior to usual care in improving
glycemic control for our critical care patients,” said Dr.
Guillermo Umpierrez
, Professor of Medicine in the Division of
Endocrinology and Metabolism at Emory University School of Medicine and
Chief of Diabetes and Endocrinology at Grady Hospital.

Dr. Jordan Messler, Executive Director of Quality Initiatives at Glytec,
adds: “We are pleased to see that Grady Hospital continues to experience
clinical excellence with eGMS® and continues to see outcomes
improvements. The results of this new study, which reflect on data from
the initial two-year period post-implementation, are consistent with the
results of an initial
study
published January 2018 in the Journal of Diabetes Science and
Technology, which looked at data over the first four months
post-implementation.”

About Glytec
Founded in 2006, Glytec is the pioneer of
digital therapeutics, improving the lives of people with diabetes by
making insulin a more effective and accessible option for millions
unable to achieve their treatment goals. The company’s patented
eGlycemic Management System® is the only FDA-cleared
software-as-a-medical-device (SaMD) platform to enable the mass
personalization of insulin across the continuum of care: inpatient,
outpatient and virtual settings alike. Glytec offers several
comprehensive programs combining evidence-based decision support
technologies with expert professional services proven to aid providers
in achieving best practices and standardization while reducing
hyperglycemia, hypoglycemia, A1C, readmissions, length of stay and cost.
The company has offices in Waltham, Massachusetts and Greenville, South
Carolina. For more information visit www.glytecsystems.com.

Contacts

Glytec
Joy Efron, 864-263-4160
Vice President Marketing
[email protected]

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

For the last half century, thousands of communications professionals have turned to us to deliver their news to the audiences most important to their business through the sources they trust most. Over that time, we've gone from a single office with one full time employee to more than 500 employees in 32 bureaus.